Electronic Consent facilitate rapid and easy implement of Informed Consent in Clinical Trials.
LOS ANGELES, CA, December 06, 2019 /Neptune100/ — Researchers including Phase I-IV Clinics and Units, with limited resources now have access to a new electronic consent platform designed to accelerate and enhance informed consent in clinical operations. ClinConsent, Inc, a leading global provider of eConsent technology, has launched ClinConsent 2.4 and a Native app for Android and iOS users.
ClinConsent provides preset configurations that will enable researchers with limited resources to automate their facilities and quickly obtain informed consent for their studies. These features include a preconfigured eConsent forms, preset system roles and recruitment screens.
Additionally, ClinConsent also supports reconsent, review and approval workflow, consent progress tracking, custom reporting on AWS cloud. ClinConsent will offer locations across the globe for hosting support, with regional offices in the U.S., and India. The package also includes standard process workflow diagrams, a validation starter kit and a “quick-start” implementation guide.
“ClinConsent’s eConsent solution has been widely recognized as the most functionally robust eConsent automation solution in the industry,” said Anil Kumar Mallikarjuna, president and CEO of ClinConsent. “However, the level of effort to implement such a robust solution and the hardware requirements necessary to host it have, in some cases, put it out of reach for some smaller CROs and Pharmas. This new prepackaged and AWS hosted solution will allow for a much shorter implementation schedule, affording the Sites and smaller clinics all the benefits of eConsent platform at a much lower total cost of ownership.”
ClinConsent, Inc. is a leading strategic eConsent software solutions provider to the life sciences industry. ClinConsent is dedicated to helping the world’s pharmaceutical, biotechnology, contract research organizations, diagnostic and device firms, and academic medical centers maximize the value of their clinical research investments. Through the use of innovative and progressive technologies, research organizations drive efficiency in clinical development, better manage risks, ensure regulatory compliance and manage their clinical operations performance.
Please visit www.clinconsent.com for more information